LDLR and atherosclerosis: In summary, in stark contrast to the findings with MerTK deficiency6, 7, hematopoietic cell-Axl deficiency in WD-fed Ldlr−/− mice does not affect the progression of advanced atherosclerosis or lesional processes associated with TAM receptor signaling.